Key facts
- There is no local search or map pack for this category, since buyers research remote monitoring, digital therapeutics, and care-coordination tools in a search-and-signup funnel rather than a near-me phone call.
- A digital therapeutic often needs actual FDA clearance, a 510(k) or De Novo pathway, before a payer will reimburse it, and a remote monitoring program bills against specific CPT codes, so the clearance and reimbursement story matters as much as the product.
- A lead in this category regularly has to survive a health system's or payer's procurement process and a security questionnaire before it counts as real pipeline, which can add weeks or months between a first click and a signed deal.
- Employer and payer budget cycles, open enrollment and fiscal-year renewal, create real seasonality that a generic SaaS launch calendar would miss entirely.
- A pilot program that never expands past its initial cohort never becomes a renewing contract, which makes the first reported outcome, not the signup itself, the real milestone to build a plan around.
How buyers actually evaluate a health tech product
Nobody in this category picks up the phone on a whim. A population-health lead at a health system, a medical policy reviewer at a payer, or a self-insured employer's benefits consultant starts by researching quietly, in search, in category comparisons, and increasingly by asking an AI assistant before a sales conversation ever begins.
Compliance and evidence get checked early, not late. If a homepage leads with clinical features but buries FDA clearance status, security attestations, and the reimbursement story, it tends to get forwarded to legal instead of turning into a signup.
Once a deal is real, it usually has to survive procurement and a security review before it counts as pipeline, which means the path from first click to signed contract can run for months, with multiple stakeholders weighing in along the way.
Even after a deal closes, the relationship isn't secure until a pilot cohort's first reported outcome lands, since that number is usually what determines whether the program expands to the full population or quietly stalls.
Which channels to run, and in what order
Start with the site itself and attribution. Clearance status, security attestations, and reimbursement details need to sit above the fold, and every demo request needs to be traceable back through procurement all the way to a closed account, not just to a first click.
Paid search and LinkedIn campaigns come next, aimed at the specific roles sitting on a buying committee: population-health leads, compliance reviewers, and benefits consultants, rather than a broad software-buyer audience.
Organic content for reimbursement, comparison, and interoperability searches builds in parallel, since these are exactly the pages a benefits consultant or health system researcher reads while building a shortlist months before a call gets booked.
Enrollment and onboarding email come last in the rollout, aimed at getting a signed program to its first reported outcome as fast as possible, since that's the number that actually gets a pilot expanded into a renewing contract.
The 90-day rollout, week by week
Weeks 1 to 4: rebuild the parts of the site that bury clearance status, security attestations, or reimbursement details, and put attribution in place so every demo request can be traced through procurement to a closed account. Launch paid search and LinkedIn campaigns aimed at population-health, IT, and compliance roles.
Weeks 5 to 8: publish reimbursement, comparison, and interoperability content aimed at the searches a benefits consultant or health system researcher runs while building a shortlist. Start mapping which accounts are stuck in procurement or security review, and build a lightweight nurture touch for those stalled deals.
Weeks 9 to 12: launch onboarding and lifecycle email built around getting a signed program to its first reported outcome as quickly as possible. Review three months of pipeline data, see which channels are producing deals that actually survive procurement, and shift budget toward those.
What this realistically costs to run
The rate card for a health tech account looks like anyone else's: managing Google and LinkedIn campaigns together costs a tenth of the monthly ad budget, $600 at the low end, with the media dollars themselves untouched by any markup.
Reimbursement, comparison, and interoperability pages cost $50 each to write and optimize, and the practical floor is ten of them in a given month.
Because a page here often needs a round of review from a clinical or regulatory team before it ships, a rebuild that finally puts clearance status and reimbursement details where a compliance reviewer will see them runs a little longer than a typical SaaS build, priced once from $1,500 climbing to $20,000 or beyond, scoped to how much clinical review the pages actually need.
The numbers to watch each month
Signups and demos matter less on their own than how many of them survive procurement and turn into a signed account, so track that conversion specifically rather than treating every demo as equal.
Watch cost per closed account by channel, not by lead, since a blended cost-per-lead number hides how much of the pipeline from any one channel actually makes it through security review.
Track time to first reported outcome for every signed pilot, since a pilot that stalls before that milestone rarely expands, no matter how good the original demo was.
What we would charge to run this
The numbers don't change for this category: a tenth of the combined Google and LinkedIn spend covers management, $600 minimum, nothing marked up on the media itself. Reimbursement and comparison content stays at $50 a page against that ten-page floor.
A site rebuild scoped around the same clearance and reimbursement details runs one time, scoped from a lean $1,500 build up to $20,000 and beyond once the clinical review requirement is known.
Billing runs month to month with no lock-in, and the opening 30 days are covered by a guarantee: fall short and there's no invoice. Walk us through your product and target buyer, and a proposal scoped to real numbers reaches you within one business day.
Related questions
Because the buyer isn't searching for something nearby. A population-health lead, a payer's medical policy team, or a benefits consultant researches a category and compares vendors nationally or globally, so the funnel is built around search, content, and demos rather than a map pack.
Clearance status, security attestations like SOC 2 or HITRUST, and the reimbursement story, placed above the fold rather than buried below product screenshots. A compliance reviewer who can't find those answers quickly tends to forward the page to legal instead of requesting a demo.
Often much longer than a typical SaaS sale, since a deal frequently has to pass through a health system's or payer's procurement process and a security questionnaire before it counts as real pipeline. That's why attribution needs to survive the whole process, not just the first click.
Because a pilot cohort that never reaches its first tracked result rarely gets expanded to the full population. Onboarding and lifecycle email built specifically around reaching that milestone quickly tends to be the difference between a pilot that renews and one that quietly stalls.
Yes. Employer open enrollment and payer fiscal-year renewal cycles create real timing patterns for this category, so a campaign calendar built around generic quarters instead of those specific cycles will miss when buyers are actually ready to move.
Want this plan built and run for you?
Get a free, no-obligation proposal within one business day. We look at your site and your market and tell you plainly what we would do, and what we would not.
Get your free proposal